Cart
sales@molnova.com
Anemoside A3
CAS No. 129724-84-1
Anemoside A3( —— )
Catalog No. M17927 CAS No. 129724-84-1
Anemoside A3 is an attractive candidate for further development as a cognitive enhancer capable of alleviating memory dysfunctions associated with aging and neurodegenerative diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 76 | In Stock |
|
| 5MG | 64 | In Stock |
|
| 10MG | 91 | In Stock |
|
| 25MG | 149 | In Stock |
|
| 50MG | 214 | In Stock |
|
| 100MG | 314 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAnemoside A3
-
NoteResearch use only, not for human use.
-
Brief DescriptionAnemoside A3 is an attractive candidate for further development as a cognitive enhancer capable of alleviating memory dysfunctions associated with aging and neurodegenerative diseases.
-
DescriptionAnemoside A3 is an attractive candidate for further development as a cognitive enhancer capable of alleviating memory dysfunctions associated with aging and neurodegenerative diseases.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetVEGFR
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number129724-84-1
-
Formula Weight750.96
-
Molecular FormulaC41H66O12
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (66.58 mM)
-
SMILES[C@H]12[C@@](CC[C@]3([C@@]4(CC[C@H]5[C@]([C@H](CC[C@@]5([C@H]4CC[C@H]13)C)O[C@@H]1OC[C@@H]([C@@H]([C@H]1O[C@@H]1O[C@H]([C@@H]([C@H]([C@H]1O)O)O)C)O)O)(C)CO)C)C)(CC[C@H]2C(=C)C)C(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ip FC, Fu WY, Cheng EY, Tong EP, et al.Anemoside A3 Enhances Cognition through the Regulation of Synaptic Function and Neuroprotection.Neuropsychopharmacology. 2015 Jul;40(8):1877-87.
molnova catalog
related products
-
Semaxinib
Semaxanib (SU5416) is a potent and selective VEGFR(Flk-1/KDR) inhibitor.
-
PKI-166
PKI-166 is an oral inhibitor of EGF-R tyrosine kinase (IC50:0.7 nM) that is both effective and selective. PKI-166 can effectively inhibit the growth and metastasis of various human cancer cells including pancreatic cancer.
-
DMH4
DMH4 is a potent and selective inhibitor of VEGFR2 with an IC50 of 0.16 μM.
